Markus Cornberg (M Cornberg)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 55

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Journal of viral hepatitis

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

Medizinische Hochschule Hannover

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medizinische Hochschule Hannover Jun 01 1999

Germany

Prof. Dr. med. :: Dept. of Gastroenterology, Hepatology and Endocrinology

Publications

Anika Wranke, Cirley Lobato, Emanoil Ceausu, Georgios N Dalekos, Mario Rizzetto, Adela Turcanu, Grazia Anna Niro, Onur Keskin, George S Gherlan, Minaam Abbas, Patrick Ingiliz, Marion Muche, Maria Buti Ferret, Mathias Jachs, Thomas Vanwolleghem, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydin, Petra Dörge, Heiner Wedemeyer, null null
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International Network. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Sophie Anna Engelskircher, Po-Chun Chen, Benedikt Strunz, Carlos Oltmanns, Tijana Ristic, Solomon Owusu Sekyere, Anke R M Kraft, Markus Cornberg, Thomas Wirth, Bernd Heinrich, Niklas K Björkström, Heiner Wedemeyer, Norman Woller
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature. Hepatology (Baltimore, Md.) 80 (1) (2024)
Sophie Anna Engelskircher, Po-Chun Chen, Benedikt Strunz, Carlos Oltmanns, Tijana Ristic, Solomon Owusu Sekyere, Anke R M Kraft, Markus Cornberg, Thomas Wirth, Bernd Heinrich, Niklas K Björkström, Heiner Wedemeyer, Norman Woller
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature. Hepatology (Baltimore, Md.) 80 (1) (2024)
Thomas F Baumert, Melanie Urbanek-Quaing, Markus Cornberg
Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus. Gut (2024)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, Tung-Hung Su, Grace Lai-Hung Wong, Wai Kay Seto, Arno Furquim d'Almeida, Margarita Papatheodoridi, Sylvia M Brakenhoff, Sabela Lens, Hannah S J Choi, Rong-Nan Chien, Jordan J Feld, Xavier Forns, Milan J Sonneveld, Georgios Papatheodoridis, Thomas Vanwolleghem, Man Fung Yuen, Henry Lik Yuen Chan, Jia-Horng Kao, Yao-Chun Hsu, Markus Cornberg, Wen-Juei Jeng, Harry L A Janssen, null null
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study). The American journal of gastroenterology (2024)
Anika Wranke, Cirley Lobato, Emanoil Ceausu, Georgios N Dalekos, Mario Rizzetto, Adela Turcanu, Grazia Anna Niro, Onur Keskin, George S Gherlan, Minaam Abbas, Patrick Ingiliz, Marion Muche, Maria Buti Ferret, Mathias Jachs, Thomas Vanwolleghem, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydin, Petra Dörge, Heiner Wedemeyer, null null
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International Network. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Markus Cornberg, Heiner Wedemeyer
Early treatment of acute or recently acquired hepatitis C: An important tool on the path to HCV elimination! Hepatology (Baltimore, Md.) (2024)
Sophie Anna Engelskircher, Po-Chun Chen, Benedikt Strunz, Carlos Oltmanns, Tijana Ristic, Solomon Owusu Sekyere, Anke R M Kraft, Markus Cornberg, Thomas Wirth, Bernd Heinrich, Niklas K Björkström, Heiner Wedemeyer, Norman Woller
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature. Hepatology (Baltimore, Md.) (2024)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, Tung-Hung Su, Grace Lai-Hung Wong, Wai Kay Seto, Arno Furquim d'Almeida, Margarita Papatheodoridi, Sylvia M Brakenhoff, Sabela Lens, Hannah S J Choi, Rong-Nan Chien, Jordan J Feld, Xavier Forns, Milan J Sonneveld, Georgios Papatheodoridis, Thomas Vanwolleghem, Man Fung Yuen, Henry Lik Yuen Chan, Jia-Horng Kao, Yao-Chun Hsu, Markus Cornberg, Wen-Juei Jeng, Harry L A Janssen, null null
Limited sustained remission after nucleos(t)ide analogue withdrawal: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study). The American journal of gastroenterology (2024)
Anika Wranke, Cirley Lobato, Emanoil Ceausu, Georgios N Dalekos, Mario Rizzetto, Adela Turcanu, Grazia Anna Niro, Onur Keskin, George S Gherlan, Minaam Abbas, Patrick Ingiliz, Marion Muche, Maria Buti Ferret, Mathias Jachs, Thomas Vanwolleghem, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydin, Petra Dörge, Heiner Wedemeyer, null null
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International Network. Liver international : official journal of the International Association for the Study of the Liver (2024)
Carlos Oltmanns, Birgit Bremer, Laura Kusche, Per Stål, Robin Zenlander, Jan Tauwaldt, Ingvar Rydén, Peter Påhlsson, Markus Cornberg, Heiner Wedemeyer
Elevation of S2-bound α1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma. Journal of viral hepatitis 31 (7) (2024)
Anja Tiede, Lena Stockhoff, Hannah Rieland, Zhaoli Liu, Jim B Mauz, Tammo L Tergast, Martin A Kabelitz, Sarah S Schütte, Alena F Ehrenbauer, Bernhard C Meyer, Heiner Wedemeyer, Jan B Hinrichs, Markus Cornberg, Christine S Falk, Cheng-Jian Xu, Benjamin Maasoumy
No value of non-selective beta-blockers after TIPS-insertion. Alimentary pharmacology & therapeutics (2024)
Carlos Oltmanns, Birgit Bremer, Laura Kusche, Per Stål, Robin Zenlander, Jan Tauwaldt, Ingvar Rydén, Peter Påhlsson, Markus Cornberg, Heiner Wedemeyer
Elevation of S2-bound α1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma. Journal of viral hepatitis (2024)
Sophie Anna Engelskircher, Po-Chun Chen, Benedikt Strunz, Carlos Oltmanns, Tijana Ristic, Solomon Owusu Sekyere, Anke R M Kraft, Markus Cornberg, Thomas Wirth, Bernd Heinrich, Niklas K Björkström, Heiner Wedemeyer, Norman Woller
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature. Hepatology (Baltimore, Md.) 80 (1) (2024)
Olympia E Anastasiou, Florin A Caruntu, Manuela G Curescu, Kendal Yalcin, Ulus S Akarca, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, Georgios Papatheodoridis, Onur Keskin, Kerstin Port, Monica Radu, Mustafa K Celen, Ramazan İdilman, Benjamin Heidrich, Ingmar Mederacke, Heiko von der Leyen, Julia Kahlhöfer, Maria von Karpowitz, Svenja Hardtke, Markus Cornberg, Cihan Yurdaydin, Heiner Wedemeyer
Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D. Liver international : official journal of the International Association for the Study of the Liver (2023)
Lisa Sandmann, Katja Deterding, Birgit Bremer, Kerstin Port, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients. Journal of viral hepatitis 30 (4) (2023)
Katja Dinkelborg, Julia Kahlhöfer, Petra Dörge, Cihan Yurdaydin, Svenja Hardtke, Florin Alexandru Caruntu, Manuela G Curescu, Kendal Yalcin, Ulus S Akarca, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, Georgios Papatheodoridis, Onur Keskin, Kerstin Port, Monica Radu, Mustafa K Celen, Ramazan İdilman, Kristina Weber, Judith Stift, Ulrike Wittkop, Benjamin Heidrich, Ingmar Mederacke, Heiko von der Leyen, Hans Peter Dienes, Markus Cornberg, Armin Koch, Michael P Manns, Heiner Wedemeyer, Katja Deterding, null null
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial. Liver international : official journal of the International Association for the Study of the Liver (2023)
Lisa Sandmann, Katja Deterding, Birgit Bremer, Kerstin Port, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients. Journal of viral hepatitis (2023)
Lisa Sandmann, Katja Deterding, Birgit Bremer, Kerstin Port, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients. Journal of viral hepatitis 30 (4) (2023)
Katja Deterding, Cheng-Jian Xu, Kerstin Port, Christopher Dietz-Fricke, Xun Jiang, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA. Journal of viral hepatitis (2023)
Lisa Sandmann, Katja Deterding, Birgit Bremer, Kerstin Port, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients. Journal of viral hepatitis 30 (4) (2023)
Lisa Sandmann, Katja Deterding, Birgit Bremer, Kerstin Port, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV infected patients. Journal of viral hepatitis (2023)
Joana Barros-Martins, Elena Bruni, Alina Suzann Fichtner, Markus Cornberg, Immo Prinz
OMIP-084: 28-color full spectrum flow cytometry panel for the comprehensive analysis of human γδ T cells. Cytometry. Part A : the journal of the International Society for Analytical Cytology 101 (10) (2022)
Valerie Ohlendorf, Maximilian Wübbolding, Paul Gineste, Christoph Höner Zu Siederdissen, Birgit Bremer, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Tammo L Tergast, Sarah Blach, Frank Tacke, Thomas Berg, Markus Cornberg, Achim Kautz, Michael Manns, Homie Razavi, Christoph Sarrazin, Yvonne Serfert, Ingo van Thiel, Stefan Zeuzem, Heiner Wedemeyer
Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany. Journal of viral hepatitis 29 (7) (2022)
Markus Cornberg, Adriana Ahumada, Alessio Aghemo, Massimo Andreoni, Abhi Bhagat, Isabel Butrymowicz, Michal Carmiel, Gabriel Chodick, Brian Conway, Yanna Song, Antonio Gasbarrini, Dietrich Hüppe, Francisco Jorquera Plaza, Pietro Lampertico, Maria Luisa Manzano Alonso, Lindsay Myles, Marcello Persico, Alnoor Ramji, Christoph Sarrazin, Erica Villa, Clara Weil, Juan Isidro Uriz Otano, null null
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study. Advances in therapy 39 (7) (2022)
Yanqin Du, Olympia E Anastasiou, Benedikt Strunz, Janina Scheuten, Birgit Bremer, Anke R M Kraft, Karolina Kleinsimglinhaus, Daniel Todt, Ruth Broering, Matthias Hardtke-Wolenski, Jun Wu, Dongliang Yang, Ulf Dittmer, Mengji Lu, Markus Cornberg, Niklas K Björkström, Tanvi Khera, Heiner Wedemeyer
The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection. Liver international : official journal of the International Association for the Study of the Liver 41 (9) (2021)
Maurizia Rossana Brunetto, Ivana Carey, Benjamin Maasoumy, Cristina Marcos-Fosch, André Boonstra, Gian Paolo Caviglia, Alessandro Loglio, Daniela Cavallone, Caroline Scholtes, Gabriele Ricco, Antonina Smedile, Mar Riveiro-Barciela, Florian van Boemmel, Annemiek van der Eijk, Fabien Zoulim, Thomas Berg, Markus Cornberg, Pietro Lampertico, Kosh Agarwal, Maria Buti Ferret
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis. Alimentary pharmacology & therapeutics 53 (6) (2021)
Hartwig Klinker, Uwe Naumann, Martin Rössle, Thomas Berg, Mark Bondin, Kristina Lohmann, Bettina Koenig, Stefan Zeuzem, Markus Cornberg
Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-Registry. Liver international : official journal of the International Association for the Study of the Liver 41 (7) (2021)
Elmira Aliabadi, Melanie Urbanek-Quaing, Benjamin Maasoumy, Birgit Bremer, Martin Grasshoff, Yang Li, Christian E Niehaus, Heiner Wedemeyer, Anke R M Kraft, Markus Cornberg
Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection. Gut (2021)
Patrick Behrendt, Birgit Bremer, Daniel Todt, Eike Steinmann, Michael Peter Manns, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy
Significant compartment-specific impact of different RNA extraction methods and PCR assays on the sensitivity of hepatitis E virus detection. Liver international : official journal of the International Association for the Study of the Liver 41 (8) (2021)
Jenny Bischoff, Stefan Mauss, Thomas Lutz, Christiane Cordes, Gerd Klausen, Stefan Scholten, Heribert Hillenbrand, Markus Cornberg, Axel Baumgarten, Jürgen K Rockstroh, null null
Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-Registry. Journal of viral hepatitis 28 (11) (2021)
Valerie Ohlendorf, Arne Schäfer, Stefan Christensen, Renate Heyne, Uwe Naumann, Ralph Link, Christoph Herold, Willibold Schiffelholz, Rainer Günther, Markus Cornberg, Yvonne Serfert, Benjamin Maasoumy, Heiner Wedemeyer, Michael R Kraus
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R). Journal of viral hepatitis 28 (8) (2021)
Lisa Sandmann, Markus Cornberg
Experimental Drugs for the Treatment of Hepatitis D. Journal of experimental pharmacology 13 (2021)
Anika Wranke, Svenja Hardtke, Benjamin Heidrich, George Dalekos, Kendal Yalçin, Fehmi Tabak, Selim Gürel, Yilmaz Çakaloğlu, Ulus S Akarca, Frank Lammert, Dieter Häussinger, Tobias Müller, Michael Wöbse, Michael P Manns, Ramazan Idilman, Markus Cornberg, Heiner Wedemeyer, Cihan Yurdaydin
Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta. Journal of viral hepatitis 27 (12) (2020)
Friederike Ebel, Katja Deterding, Kerstin Port, Bernhard Schlevogt, Michael P Manns, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer
Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis. Alimentary pharmacology & therapeutics 51 (1) (2020)
Birgit Bremer, Olympia Evdoxia Anastasiou, Svenja Hardtke, Florin Alexandru Caruntu, Manuela G Curescu, Kendal Yalcin, Ulus S Akarca, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, Georgios Papatheodoridis, Monica Radu, Ramazan Idilman, Michael P Manns, Markus Cornberg, Cihan Yurdaydin, Heiner Wedemeyer
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study. Liver international : official journal of the International Association for the Study of the Liver 41 (2) (2020)
Homie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, Markus Cornberg
Response to Taiwan is on track of accelerating hepatitis C elimination by 2025. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Kathrin Heim, Benedikt Binder, null Sagar, Dominik Wieland, Nina Hensel, Sian Llewellyn-Lacey, Emma Gostick, David A Price, Florian Emmerich, Hildegard Vingerhoet, Anke R M Kraft, Markus Cornberg, Tobias Boettler, Christoph Neumann-Haefelin, Dietmar Zehn, Bertram Bengsch, Maike Hofmann, Robert Thimme
TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection. Gut (2020)
Christian E Niehaus, Benedikt Strunz, Martin Cornillet, Christine S Falk, Ansgar Schnieders, Benjamin Maasoumy, Svenja Hardtke, Michael P Manns, Anke R M Kraft, Niklas K Björkström, Markus Cornberg
MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis. Hepatology (Baltimore, Md.) 72 (4) (2020)
Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Yung-Chang Lin, Sebastian Binder, Christine Falk, Jennifer Debarry, Paul Gineste, Anke R M Kraft, Rong-Nan Chien, Benjamin Maasoumy, Heiner Wedemeyer, Wen-Juei Jeng, Michael Meyer Hermann, Markus Cornberg, Christoph Höner Zu Siederdissen
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg-Negative CHB. Hepatology communications 5 (1) (2020)
Dorothea Bankwitz, Akash Bahai, Maurice Labuhn, Mandy Doepke, Corinne Ginkel, Tanvi Khera, Daniel Todt, Luisa J Ströh, Leona Dold, Florian Klein, Frank Klawonn, Thomas Krey, Patrick Behrendt, Markus Cornberg, Alice C McHardy, Thomas Pietschmann
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies. Gut 70 (9) (2020)
Olympia Evdoxia Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, Svenja Hardtke, Florin Alexandru Caruntu, Manuela G Curescu, Kendal Yalcin, Ulus S Akarca, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, Georgios Papatheodoridis, Monica Radu, Stephanie Liebig, Heike Bantel, Birgit Bremer, Michael P Manns, Markus Cornberg, Heiner Wedemeyer
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction. Journal of viral hepatitis 28 (2) (2020)
Markus Cornberg, Dieter Glebe
Editorial: which factors influence HBsAg levels in HBV-infected patients? Alimentary pharmacology & therapeutics 52 (3) (2020)
Julia Hengst, Andreas L Klein, Sebastian Lunemann, Katja Deterding, Svenja Hardtke, Christine S Falk, Michael P Manns, Markus Cornberg, Verena Schlaphoff, Heiner Wedemeyer
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection. Journal of viral hepatitis 26 (4) (2019)
Homie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, Markus Cornberg
Global timing of hepatitis C virus elimination in high-income countries. Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2019)
Freya Wellhöner, Nico Döscher, Tammo Lambert Tergast, Marius Vital, Iris Plumeier, Silke Kahl, Andrej Potthoff, Michael Peter Manns, Benjamin Maasoumy, Heiner Wedemeyer, Markus Cornberg, Dietmar Helmut Pieper, Benjamin Heidrich
The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients. Scandinavian journal of gastroenterology 54 (8) (2019)
Franziska Rinker, Corinna M Bremer, Kathrin Schröder, Steffen B Wiegand, Birgit Bremer, Michael P Manns, Anke R M Kraft, Heiner Wedemeyer, Lei Yang, Vedran Pavlovic, Cynthia Wat, Wolfram H Gerlich, Dieter Glebe, Markus Cornberg
Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
Jenny Bischoff, Stefan Mauss, Christiane Cordes, Thomas Lutz, Stefan Scholten, Markus Cornberg, Michael P Manns, Axel Baumgarten, Jürgen K Rockstroh
Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry. HIV clinical trials 19 (6) (2019)
Tammo L Tergast, Markus Kimmann, Hans Laser, Svetlana Gerbel, Michael P Manns, Markus Cornberg, Benjamin Maasoumy
Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis. Alimentary pharmacology & therapeutics 50 (6) (2019)
Christoph Höner Zu Siederdissen, Benjamin Maasoumy, Markus Cornberg
New viral biomarkers for Hepatitis B: Are we able to change practice? Journal of viral hepatitis 25 (11) (2019)
Frank Tacke, Klaus H W Boeker, Hartwig Klinker, Renate Heyne, Peter Buggisch, Anita Pathil, Johannes Wiegand, Markus Cornberg, Christian Lange, Florian van Boemmel, Stefan Zeuzem, Stefan Mauss
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs. Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2019)
Henry Lik Yuen Chan, D Messinger, Georgios Papatheodoridis, Markus Cornberg, Q Xie, T Piratvisuth, H Ren, P T Kennedy, A Thompson, A Caputo, G Bakalos, Vedran Pavlovic, Pietro Lampertico
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 48 (5) (2018)
Markus Cornberg, J Petersen, A Schober, S Mauss, K H W Böker, R Link, R Günther, Y Serfert, H Pfeiffer-Vornkahl, M P Manns, C Sarrazin, D Hüppe, T Berg, C Niederau
Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection. Alimentary pharmacology & therapeutics 45 (5) (2017)
Christoph Höner Zu Siederdissen, Bernhard Schlevogt, Philipp Solbach, Kerstin Port, Markus Cornberg, Michael P Manns, Heiner Wedemeyer, Katja Deterding
Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment. Liver international : official journal of the International Association for the Study of the Liver 38 (5) (2017)

Markus Cornberg.css-eqlu8i{font-size:small;padding-left:4px;} (M Cornberg)

Publication Activity (10 Years)

Top Topics

Top Venues

Markus Cornberg (M Cornberg)